Basal cell carcinoma: Difference between revisions
ClaireLewis (talk | contribs) |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
===Risk Factors=== | ===Risk Factors=== | ||
*UV radiation | *UV radiation | ||
*Chronic arsenic exposure | *Chronic [[arsenic]] exposure | ||
*Ionizing radiation | *Ionizing radiation | ||
*Immunosuppression | *Immunosuppression | ||
| Line 24: | Line 24: | ||
==Management== | ==Management== | ||
*Not typically managed within ED | |||
==Disposition== | ==Disposition== | ||
*Discharge with derm follow up | |||
==See Also== | ==See Also== | ||
Revision as of 23:59, 30 September 2019
Background
- Most common skin malignancy
- Rarely a metastatic process
Risk Factors
- UV radiation
- Chronic arsenic exposure
- Ionizing radiation
- Immunosuppression
Clinical Features
- Slow growing
- Usually head and neck
- Only where hair follicles exist
- Pearly nodule with telangiectatic vessels, rolled border and central ulceration
Differential Diagnosis
Other Rash
- Acute generalized exanthematous pustulosis
- Allergic reaction
- Aphthous stomatitis
- Atopic dermatitis
- Coxsackie
- Dermatitis herpetiformis
- Exfoliative erythroderma
- Impetigo
- Pellagra
- Pityriasis rosea
- Serum Sickness
- Tinea capitus
- Tinea corporis
- Vitiligo
Evaluation
- Clinical examination by trained clinician (dermatology referral)
- Skin biopsy
Management
- Not typically managed within ED
Disposition
- Discharge with derm follow up